HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 2,755.00
+260.00 (10.42%)
Nov 2, 2026, 3:30 PM KST
HLB Therapeutics Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 64,447 | 69,561 | 54,932 | 52,591 | 42,403 | 43,586 |
Revenue Growth | 5.25% | 26.63% | 4.45% | 24.03% | -2.72% | 1.53% |
Gross Profit Gross Profit Growth | 4,021 | 10,032 | 9,979 | 7,184 | 8,721 | 5,007 |
Operating Income Operating Income Growth | -9,302 | -3,582 | -7,624 | -8,869 | -7,507 | -11,087 |
Net Income Net Income Growth | -18,022 | -9,227 | -22,793 | -2,302 | -11,354 | -17,197 |
Earnings Per Share EPS Growth | -204.99 | -105.00 | -262.07 | -28.15 | -158.92 | -266.85 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Headquarters and Bio Business Headquarters and Bio Business Growth | 5,074 | 4,567 | 3,408 | 384.33 | 200.81 | 189.68 |
Cold Chain Business Cold Chain Business Growth | 53,378 | 58,816 | 45,934 | 43,500 | 14,007 | 32,077 |
Electronics Business Electronics Business Growth | 11,069 | 10,745 | 8,998 | 9,090 | 9,982 | 11,472 |
Inter-Segment Inter-Segment Growth | - | -4,567 | -3,408 | -384.33 | -1,542 | -152.71 |
Total Total Growth | 64,447 | 69,561 | 54,932 | 52,591 | 48,132 | 43,586 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,235 | 45,998 | 37,773 | 32,353 | 64,012 | 100,567 |
Total Debt Total Debt Growth | 40,436 | 40,550 | 23,353 | 10,022 | 52,131 | 51,126 |
Net Cash (Debt) Net Cash Growth | -27,201 | 5,448 | 14,420 | 22,330 | 11,881 | 49,441 |
Net Cash Growth | - | -62.22% | -35.42% | 87.95% | -75.97% | 219.98% |
Net Cash Per Share Net Cash Per Share Growth | -308.57 | 61.84 | 165.80 | 273.07 | 166.30 | 767.17 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,887 | -8,178 | 1,288 | 3,327 | -8,809 | -11,268 |
Capital Expenditures CapEx Growth | -841.51 | -1,285 | -636.97 | -301.76 | -3,396 | -822.87 |
Free Cash Flow Free Cash Flow Growth | -4,728 | -9,463 | 650.79 | 3,025 | -12,204 | -12,091 |
Free Cash Flow Growth | - | - | -78.49% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 6.24% | 14.42% | 18.17% | 13.66% | 20.57% | 11.49% |
Operating Margin | -14.43% | -5.15% | -13.88% | -16.86% | -17.70% | -25.44% |
Pretax Margin | -31.08% | -15.94% | -41.74% | -5.64% | -27.29% | -40.76% |
Profit Margin | -27.96% | -13.26% | -41.49% | -4.38% | -26.78% | -39.45% |
FCF Margin | -7.34% | -13.60% | 1.19% | 5.75% | -28.78% | -27.74% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 236.63 | 236.63 | 236.63 | 236.63 | 236.63 |
P/FCF Ratio | - | - | 1435.95 | 109.54 | - | - |
PS Ratio | 3.41 | 3.62 | 17.01 | 6.30 | 8.61 | 8.69 |